Mounting Evidence Shows Health Benefits of Grape Polyphenols
Grapes and grape extracts may lower cardiovascular disease risk, says review in Nutrition Research
Philadelphia, PA, October 28, 2008 – A growing body of research data suggests that consuming foods rich in polyphenols from grapes—including red wine—helps reduce the risk of heart disease, according to a review article in the November issue of Nutrition Research.
"Consumption of grape and grape extracts and/or grape products such as red wine may be beneficial in preventing the development of chronic degenerative diseases such as cardiovascular disease," write Wayne R. Leifert, Ph.D., and Mahinda Y. Abeywardena, Ph.D., of Commonwealth Scientific and Industrial Research Organisation in Adelaide, Australia.
The authors review the accumulating evidence that grape polyphenols work in many different ways to prevent cardiovascular and other "inflammatory-mediated" diseases. Polyphenols are natural antioxidants found in grapes and some other plant foods. Their types and actions vary, depending on where in the grape they are found. Grape seeds, grape skin, and grape juice contain several types of polyphenols, including resveratrol, phenolic acids, anthocyanins, and flavonoids.
Through their antioxidant effects, grape polyphenols help to slow or prevent cell damage caused by oxidation. Polyphenols decrease oxidation of low-density lipoprotein cholesterol ("bad" cholesterol)—a key step in the development of atherosclerosis (hardening of the arteries).
Grape polyphenols also have other protective effects on the heart and blood vessels, including actions to reduce blood clotting, abnormal heart rhythms, and blood vessel narrowing. It's not yet clear exactly how these benefits of polyphenols occur, although there is evidence of effects on cellular signaling and on the actions of certain genes. The wide range of health-promoting effects suggests that several different, possibly interrelated mechanisms may be involved.
So far, most of the evidence on grape polyphenols comes from laboratory experiments and animal studies. However, a few studies support the disease-preventing benefits of grapes in humans. Studies in patients treated with grape seed extracts have shown improvements in blood flow and cholesterol levels. In other studies, drinking Concord grape juice has improved measures of blood flow in patients with coronary artery disease and lowered blood pressure in patients with hypertension.
Studies investigating the lower rates of heart disease in France—the so-called "French paradox"—first raised the possibility that red wine might have health benefits. The subsequent research reviewed by Drs. Leifert and Abeywardena helps build the case that grapes and grape products might be a useful part of strategies to lower the high rate of death from cardiovascular disease.
At a time of growing interest in the use of "functional foods and nutraceuticals" to promote heart health, grapes and grape polyphenols are "attractive candidates" for use in such supplements, Drs. Leifert and Abeywardena believe. "Therefore," they conclude, "supplementation with grape seed, grape skin or red wine products may be a useful adjunct to consider for a dietary approach in the prevention of cardiovascular diseases, although additional research is required to support such a strategy."
# # #
Notes to Editors:
Full text of the article mentioned above is available upon request. Contact Jayne M. Dawkins at (215) 239-3674 or email@example.com to obtain a copy or to schedule an interview. The article will appear in the November issue of Nutrition Research, published by Elsevier.
About Nutrition Research
Nutrition Research publishes research articles, communications, and reviews on all aspects of basic and applied nutrition. The mission of Nutrition Research is to serve as the journal for global communication of nutrition and life sciences research on food and health. The field of nutritional sciences includes, but is not limited to, the study of nutrients during growth, reproduction, athletic performance, aging, and disease. A principal focus of the journal is to publish research that advances the understanding of nutrients and health protectants in food for improving the human condition.
Elsevier is a global information analytics business that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com
+1 215 239 3674